semaglutide for kidney failure just got FDA-approved disease. This changes everything., January 2025. The FDA approved semaglutide (Ozempic/Wegovy) for a new indication: reducing kidney disease progression in clinicaltrials #medicalresearch | NEJM Group

While the diet may diminish symptoms, it will not diminish the size of any tumors present

This is where a functional medicine approach is essential

Cost Plus Drugs and CenterWell hope to lure other employers to their employee prescription benefit model

BlueCross BlueShield of Tennessee, the state's largest commercial insurer, typically places Rybelsus on its specialty or non-preferred brand tier

This could indicate a more serious issue such as gastroparesis (stomach paralysis) or an intestinal blockage, which are serious side effects that have been associated with GLP-1 medications in some cases

I would eat three servings of pasta for dinner and not even bat an eyelash